ChatAbout Dr. Mohd Syahizul Nuhairy Bin Mohd Sharial
- Dr. Mohd Syahizul Nuhairy Bin Mohd Sharial is a medical oncologist with more than 15 years of expertise.
- Services provided by him includes medical oncology, breast cancer, brain tumor, lung cancer, and many more.
- He earned his MBBCh BAO from University College Dublin in 2002, his MRCP from the Royal College of Physicians of Ireland in 2008, and his ESMO from the European Society for Medical Oncology in 2010.
- He is registered with 129351 (National Specialist Register of Malaysia, 2013) and 54838 (Malaysian Medical Council, 2012).
- Dr. Mohd Syahizul Nuhairy Bin Mohd Sharial is fluent in English, and Malay.
Hospital
Pantai Hospital Manjung
Hospital Location
Manjung, Malaysia 
LocationSpecial Interest
Medical Oncology Cancer diagnosis Cancer treatment Brain Tumor Breast cancer
List Of Treatments
- Metastatic Tumors Treatment
- Chemotherapy
- Radiotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Bile Duct Cancer Treatment
- Bladder Cancer Treatment
- Bone Cancer Treatment
- Breast Cancer-Surgical
- Cancer in Children
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Esophagus Cancer Treatment
- Ewing Family of Tumors Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Carcinoid Tumors Treatment
- Gastrointestinal Stromal Tumor GIST Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Kaposi Sarcoma Treatment
- Kidney Cancer Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukemia - ALL in Adults
- Leukemia in Children
- Liver Cancer
- Lung Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Small-cell Carcinoma Treatment
- Lung Carcinoid Tumor Treatment
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Neuroblastoma
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Oral Cavity and Oropharyngeal Cancer
- Osteosarcoma (OS) Treatment
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Salivary Gland Cancer
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Basal Cell and Squamous Cell Carcinoma
- Skin Cancer - Melanoma
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Waldenstrom Macroglobulinemia
- Wilms Tumor (Nephroblastoma)
- Breast Biopsy
- Pediatric Bone Marrow Transplant
- Oral Cancer - Surgical
- Breast Cancer
- Leukemia Treatment
- Hairy Cell Leukemia - HCL
- Fallopian Tube Cancer
- Ovarian Germ Cell Tumor
- Ovarian Primary Peritoneal Cancer
- Medullary Carcinoma
- Papillary Thyroid Cancer Treatment
- Bone Marrow Cancer
- Ovarian Sex Cord Stromal Tumor
- Invasive Lobular Carcinoma
- Colon Cancer Treatment
- Cancer Treatment
- Adenocarcinoma - Glandular Cancer Treatment
- Immunotherapy
- Transarterial Chemoembolization - TACE
- Breast Conservation Surgery - BCS
- Breast Lumpectomy
- IMRT
- HIPEC
- Parathyroidectomy
- Lobectomy
- Completion Thyroidectomy
Work Experience of Dr. Mohd Syahizul Nuhairy Bin Mohd Sharial
Consultant, Pantai Hospital Manjung
Consultant, Pantai Hospital Ipoh, Ipoh
Dr. Mohd Syahizul Nuhairy Bin Mohd Sharial's
- , 2010, ESMO (Medical Oncology), European Society for Medical Oncology,Switzerland)
- MRCP, 2008, Royal College of Physicians of Ireland, Ireland
- , 2002, MBBCh BAO, University College Dublin, ireland
- Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer
- Primary central nervous system lymphoma: The influence of radiotherapy on patient outcome in an unselected population.
- Prognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: Impact of baseline fluctuation and changes during chemotherapy
- A 10-year review of primary CNS lymphoma treatments and outcome: The Irish experience.
- 43P CONDITIONAL PROBABILITY OF SURVIVAL IN SMALL CELL LUNG CANCER
- Is survival in advanced pancreas cancer (APC) correlated to treatment-related lymphopenia (TRL)?
- Influence of ABO blood group on the natural history of advanced pancreatic adenocarcinoma (PC).
- Does interval from histologic diagnosis (Dx) to start of chemotherapy (Ctx) influence survival in advanced pancreatic adenocarcinoma (PC)?
- Genitourinary tumors, prostate
- Predictive and Prognostic Roles of Body Mass Index (BMI) in Docetaxel(D)-Treated Castrate-Resistant Prostate Cancer (CRPC)
- Mohd Sharial MS, Crown J, Hennessy BTOvercoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer. Ann Oncol 23(12): 3007-3016
- Modern imaging technique assessment of small cell lung cancer doubling time.
- Hypertrophic osteoarthropathy leading to the diagnosis of primitive neuroectodermal tumour (PNET)
Wondering where to start?
(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)
